Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2017 | 11-2013 | 11-2012 | 11-2011 | |
| Sales | 0 | 0 | 814,318 | 1,158,898 | 1,448,476 |
| Cost of Goods | N/A | N/A | 643,237 | 963,062 | 1,226,404 |
| Gross Profit | N/A | N/A | 171,081 | 195,836 | 222,072 |
| Operating Expenses | 1,042 | 0 | 173,533 | 179,435 | 191,495 |
| Operating Income | -1,042 | N/A | -2,215 | 16,463 | 30,981 |
| Interest Expense | 10 | 0 | 1 | 2 | 5 |
| Other Income | 93 | 0 | 258 | 801 | 397 |
| Pre-tax Income | -959 | 0 | -1,958 | 17,262 | 31,373 |
| Income Tax | N/A | N/A | 19,253 | -398 | 3,076 |
| Net Income Continuous | -959 | N/A | -21,211 | 17,660 | 28,297 |
| Net Income | $-959 | $N/A | $-21,211 | $17,660 | $28,297 |
| EPS Basic Total Ops | -1.28 | N/A | -0.77 | 0.64 | 0.96 |
| EPS Basic Continuous Ops | -1.30 | N/A | -0.77 | 0.64 | 0.96 |
| EPS Diluted Total Ops | -1.28 | N/A | -0.77 | 0.63 | 0.92 |
| EPS Diluted Continuous Ops | -1.30 | N/A | -0.77 | 0.63 | 0.92 |
| EPS Diluted Before Non-Recurring Items | -0.09 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,027 | $N/A | $15,602 | $37,553 | $56,792 |